Cargando…
Nexavar(®)-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012
Hepatocellular carcinoma (HCC) remains a major global health problem and Calabria in the south of Italy is not an exception. Sorafenib is the first and only Food and Drug Administration approved drug for the treatment of advanced HCC and it is currently under intensive monitoring by the Health Autho...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853677/ https://www.ncbi.nlm.nih.gov/pubmed/24347990 http://dx.doi.org/10.4103/0976-500X.120971 |